Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Zoster Vaccine in Stable SLE Patients
NCT04516408Unknown
- Sponsor
- Renji Hospital
- Start
- Apr 2021
- Primary completion
- Sep 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial in herpes zoster (HZ) comparing Recombinant zoster vaccine with Placebo (2 arms). Primary endpoint: Percent of participants with herpes zoster at 12 months. Status: unknown.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT04516408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04516408.